Stockpolly
Search
ECOR · NASDAQ · Medical - Devices

electroCore (ECOR)

Makes prescription and consumer devices using non-invasive vagus-nerve stimulation.

$9.60
At close+0.55 (+6.08%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue5556777799109
Cost of revenue111111111111
Gross profit445556667888
888889101010111411
Research & development110111111111
Selling, general & administrative7787889910101310
Operating income−4−4−4−3−3−3−4−4−3−3−5−3
00000000−1000
Interest income000000000000
Interest expense000000000000
Other non-operating income000000000000
Income before tax−4−4−4−3−2−3−4−4−3−3−6−3
Income tax expense000000000000
Net income from continuing operations−4−4−4−3−2−3−4−4−3−3−5−3
Net income−4−4−4−3−2−3−4−4−3−3−5−3
EPS, basic−$0.68−$0.61−$0.53−$0.38−$0.31−$0.43−$0.47−$0.44−$0.40−$0.38−$0.59−$0.33
EPS, diluted−$0.68−$0.61−$0.53−$0.38−$0.31−$0.43−$0.47−$0.44−$0.40−$0.38−$0.59−$0.33
Weighted average shares, basic677787888899
Weighted average shares, diluted677787888899
EBITDA−4−4−3−2−2−3−4−4−3−1−5−3
Depreciation & amortization000001000100
EBIT−4−4−4−3−2−3−4−4−3−3−5−3